Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Weight Maintenance After Injectable Orforglipron ATTAIN-MAINTAIN demonstrated that patients switching from tirzepatide to orforglipron maintained their previously achieved weight loss, validating oral step-down maintenance therapy
This medication works by enhancing insulin secretion in response to meals, reducing glucagon release, and slowing gastric emptying
Animal studies show embryo-fetal toxicity
The ratio of reduced GSH to the disulfide form (GSH/GSSG) within the endoplasmic reticulum ranges from 1:1 to 4:1, whereas the overall cellular GSH/GSSG ratio ranges from 30:1 to 100:1 (Figure 2)
US$ 20.01
US$ 25.50
US$ 20.70
US$ 24.65
US$ 22.96
US$ 29.61
US$ 20.71
US$ 23.46
US$ 27.83
US$ 29.07
US$ 27.60
